The practical sweet spot lands between 300-500mcg daily for most individuals
Molecular Characteristics Molecular Type: Synthetic growth hormone fragment research peptide Structure: Linear peptide chain Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name AOD9604 6mg cas 386264-39-7 purity 99% (HPLC verified) unit Size 6 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored appropriately Analytical Validation and Quality Control High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and weight verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement AOD9604 6mg is supplied strictly for laboratory research and scientific investigation
10.1186/s13011-023-00573-8 23 GriffithsS.HenshawR.McKayF
& Motea, E
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
